Finanzen von ZimVie Inc (ZIMV)ZIMVZimVie Inc

ZimVie Inc (ZIMV) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Dental, accounting for 51.9% of total sales, equivalent to $105.31M. Another important revenue stream is Spine. Understanding this composition is critical for investors evaluating how ZIMV navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, ZimVie Inc maintains a gross margin of 59.25%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.33%, while the net margin is -3.30%. These profitability ratios, combined with a Return on Equity (ROE) of -4.76%, provide a clear picture of how effectively ZIMV converts its operational activities into shareholder value.

In the context of the broader market, ZIMV competes directly with industry leaders such as BFLY and AVNS. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ZIMV's gross margin of 59.25% stands against BFLY's 71.41% and AVNS's 51.70%. Such benchmarking helps identify whether ZimVie Inc is trading at a premium or discount relative to its financial performance.